Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma

NCT02186834

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

NCT02171078

Conditions: Breast Diseases, Breast Neoplasms, Disease Attributes, +7 more
Locations: University of Wisconsin-Madison School of Medicine and Public Health Madison, Wisconsin, United States

View Trial Details

Completed

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

NCT00559091

Conditions: Acute Myelocytic Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: McMaster Hospital Hamilton, Ontario, Canada

Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada

Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Completed

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

NCT03873493

Conditions: Cancer, Disease Attributes, Hematologic Diseases, +16 more
Locations: Dana-Farber Cancer Institute /ID# 207728 Boston, Massachusetts, United States

Mayo Clinic - Rochester /ID# 207692 Rochester, Minnesota, United States

University of Texas MD Anderson Cancer Center /ID# 207746 Houston, Texas, United States

Peter MacCallum Cancer Ctr /ID# 209554 Melbourne, Victoria, Australia

View all 15 locations

View Trial Details

Completed

Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation

NCT03456726

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: 1004 Eisai Trial Site Nagoya, Aichi-ken, Japan

1029 Eisai Trial Site Nagoya, Aichi-ken, Japan

1020 Eisai Trial Site Ōta, Gunma, Japan

1007 Eisai Trial Site Sapporo, Hokkaido, Japan

View all 28 locations

View Trial Details

Completed

Mesh and Mesh Fixation in Laparoscopic Groin Hernia Surgery

NCT03755219

Conditions: Disease Attributes, Fixation Device; Complications, Hernia, +11 more
Locations: Not specified

View Trial Details

Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations: TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States

TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States

TG Therapeutics Investigational Trial Site Athens, Georgia, United States

TG Therapeutics Investigational Trial Site Macon, Georgia, United States

View Trial Details

Completed

A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

NCT03114254

Conditions: Disease Attributes, Genital Diseases, Genital Diseases, Male, +14 more
Locations: Bristol Haematology and Oncology Centre, Horfield Road Bristol, United Kingdom

Universitty College Hospitals NHS Trust London, United Kingdom

View Trial Details

Completed

A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck

NCT03620123

Conditions: Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +11 more
Locations: Essen University Hospital Essen, Germany

View Trial Details

Completed

A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT03009344

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Eisai Trial Site Isehara, Kanagawa, Japan

Eisai Trial Site Chuo-ku, Tokyo, Japan

View Trial Details

Recurrence

Recurrence trial results

Related conditions